MONTAI
Live / Registered — Registered (as of 12 Mar 2024)
What this means for you
Registered since 12 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90271751
- Registration number
- 7327833
- Mark type
- Stylized text
- Filed
- 22 Oct 2020
- Published for opposition
- 05 Oct 2021
- Registered
- 12 Mar 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Nutritional supplements; medical foods, namely, infant, pediatric and adult formulas being dietetic beverages for nutrition purposes; pharmaceutical and therapeutic products, namely, pharmaceutical preparations for the treatment of immunological or metabolic diseases, infectious disease, nutritional deficiencies, oncological disease
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of nutritional supplements, therapeutics, and pharmaceuticals
Owner
- MONTAI THERAPEUTICS, INC., CAMBRIDGE, MA, US
- MONTAI HEALTH, INC., CAMBRIDGE, MA, US
- MONTAI HEALTH, INC., CAMBRIDGE, MA, US
- MONTAI HEALTH, INC., CAMBRIDGE, MA, US
- Flagship Labs 65, Inc., Cambridge, MA, US
Prosecution history
- 08 May 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Jan 2024 — USE AMENDMENT FILED
- 08 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Jan 2024 — TEAS STATEMENT OF USE RECEIVED
- 06 Dec 2023 — ASSIGNED TO EXAMINER
- 29 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Nov 2023 — SOU EXTENSION 4 GRANTED
- 28 Nov 2023 — SOU EXTENSION 4 FILED
- 28 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 30 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED